Sep 25, 2020
FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%
Sep 24, 2020
Bausch Health Announces VYZULTA® (Latanoprostene Bunod Ophthalmic Solution), 0.024%, is Now Approved In Seven Countries
Aug 31, 2020
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From Operations
Aug 11, 2020
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
Aug 06, 2020
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
Aug 06, 2020
Bausch Health Companies Inc. Announces Second-Quarter 2020 Results
Jul 31, 2020
Bausch Health Resolves Legacy SEC Investigation
Jul 23, 2020
Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6
Jun 23, 2020
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
Jun 16, 2020
Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference
Jun 15, 2020
Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients
Jun 04, 2020
FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE(TM) Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses
May 11, 2020
Bausch Health Announces Pricing And Upsize Of Private Offering Of Senior Notes And Prepayment Of Term Loan 2022 Mandatory Amortization
May 07, 2020
Bausch Health Companies Inc. Announces First-Quarter 2020 Results
May 06, 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Apr 30, 2020
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
Apr 29, 2020
FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
Apr 23, 2020
Bausch Health Companies Inc. Will Release First-Quarter 2020 Financial Results On May 7
Apr 14, 2020
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
Apr 02, 2020
Bausch Health Companies Inc. Will Hold Virtual Annual Meeting Of Shareholders On April 28